Kaplan-Meier analyses revealed, that ccRCC patients with elevated AR expression of over 5% showed a significantly longer time to progression than low/no AR expressing tumors, in papRCC-patients a trend can be observed (Supplementary Figure 2, 3). The gene discussed is AR; the disease is nonpapillary renal cell carcinoma.